Clinical Guidelines


Hepatocellular Carcinoma

Hepatocellular Carcinoma

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia 2023

Liver cancer incidence and mortality rates are growing faster than any other cancer in Australia. Between 1982 and 2019 the age-standardised incidence rate for liver cancer increased by 378% and the age-standardised mortality rate increased 204%. In response to these increasing rates, Cancer Council Australia and The Daffodil Centre were commissioned by the Australian Government of Health and Aged Care to develop a Roadmap and clinical guidelines for liver cancer control in Australia.

The intended outcomes of the Roadmap are to provide recommendations for priority actions to reduce liver cancer burden over the next five, 10 and 20 years; and to develop clinical practice guidelines which will support health professionals to deliver best practice for enhanced liver cancer control.

The development of these Guidelines has been led by eminent clinicians in the area of liver disease and liver cancer, Co-Chairs Professor Jacob George and Dr Nicole Allard, alongside a multi-disciplinary working party, including healthcare and clinical representatives, representatives with lived experience and other community representatives. 

Public Consultation

It is now closed. 

WEBSITE UPDATES - This website was last updated 10/16/2022